- Home
- HCWB vs EHLD Comparison
HCWB vs EHLD Comparison
Compare HCWB & EHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- EHLD
- Stock Information
- Founded
- HCWB 2018
- EHLD 2024
- Country
- HCWB United States
- EHLD Greece
- Employees
- HCWB N/A
- EHLD N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- EHLD
- Sector
- HCWB Health Care
- EHLD
- Exchange
- HCWB Nasdaq
- EHLD NYSE
- Market Cap
- HCWB 16.1M
- EHLD 17.2M
- IPO Year
- HCWB 2021
- EHLD N/A
- Fundamental
- Price
- HCWB $4.44
- EHLD $7.75
- Analyst Decision
- HCWB Strong Buy
- EHLD
- Analyst Count
- HCWB 1
- EHLD 0
- Target Price
- HCWB $35.00
- EHLD N/A
- AVG Volume (30 Days)
- HCWB 236.1K
- EHLD 51.1K
- Earning Date
- HCWB 08-13-2025
- EHLD 06-25-2025
- Dividend Yield
- HCWB N/A
- EHLD N/A
- EPS Growth
- HCWB N/A
- EHLD N/A
- EPS
- HCWB N/A
- EHLD N/A
- Revenue
- HCWB $1,445,145.00
- EHLD $15,640,631.00
- Revenue This Year
- HCWB N/A
- EHLD N/A
- Revenue Next Year
- HCWB N/A
- EHLD N/A
- P/E Ratio
- HCWB N/A
- EHLD $5.75
- Revenue Growth
- HCWB N/A
- EHLD N/A
- 52 Week Low
- HCWB $3.55
- EHLD $3.83
- 52 Week High
- HCWB $100.80
- EHLD $12.80
- Technical
- Relative Strength Index (RSI)
- HCWB 28.61
- EHLD N/A
- Support Level
- HCWB $4.05
- EHLD N/A
- Resistance Level
- HCWB $5.77
- EHLD N/A
- Average True Range (ATR)
- HCWB 0.49
- EHLD 0.00
- MACD
- HCWB -0.07
- EHLD 0.00
- Stochastic Oscillator
- HCWB 9.98
- EHLD 0.00
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About EHLD EUROHOLDINGS LTD
Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.